{"nct_id":"NCT01636817","title":"A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics","status":"TERMINATED","status_verified_date":"2018-09","start_date":"2012-08","start_date_type":null,"primary_completion_date":"2014-11","primary_completion_date_type":"ACTUAL","completion_date":"2014-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVO"]}